• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LLY

LLY

Eli Lilly and Company

NYSEHealthcareDrug Manufacturers - GeneralUS

USD1083.23

+19.08 (+1.79%)

Rating:B

Company Profile

CEO

David A. Ricks

IPO Date

1972-06-01

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NYSE

Country

US

Market Metrics

Open

$1059.50

Prev. Close

$1064.15

Day Low

$1053.51

Day High

$1093.28

52W Low

$623.78

52W High

$1149.10

Market Cap

$1020.12B

Volume

1.97M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.2%

Avg Negative

2.6%

Avg Neutral

52.2%

News Feed

Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

seekingalpha.com·5/28/2026·↑ positive

Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win

seekingalpha.com·5/28/2026·↑ positive

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost

fool.com·5/28/2026·↓ negative

CVS brings back coverage for Lilly's obesity drug Zepbound

reuters.com·5/28/2026·↑ positive

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

cnbc.com·5/28/2026·↑ positive

Foundayo and Zepbound now covered for millions of Americans

prnewswire.com·5/28/2026·↑ positive

Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion

zacks.com·5/27/2026·↑ positive

President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?

fool.com·5/27/2026·↑ positive

Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts

zacks.com·5/27/2026·↑ positive

Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference

prnewswire.com·5/27/2026·↑ positive